Market Value186,779,622
Total Holdings45
File Date2026-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TVTX / Travere Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
MNMD / Mind Medicine (MindMed) Inc.
CDTX / Cidara Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
PTN / Palatin Technologies, Inc.
TSHA / Taysha Gene Therapies, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
RZLT / Rezolute, Inc.
SION / Sionna Therapeutics, Inc.
SPRB / Spruce Biosciences, Inc.
ENTX / Entera Bio Ltd.
REGN / Regeneron Pharmaceuticals, Inc.
TECX / Tectonic Therapeutic, Inc.
PTGX / Protagonist Therapeutics, Inc.
AARD / Aardvark Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
ASMB / Assembly Biosciences, Inc.
AVTX / Avalo Therapeutics, Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
DNTH / Dianthus Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
FULC / Fulcrum Therapeutics, Inc.
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
PALI / Palisade Bio, Inc.
PVLA / Palvella Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
NBP / NovaBridge Biosciences - Depositary Receipt (Common Stock)
TERN / Terns Pharmaceuticals, Inc.
TRVI / Trevi Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
VRDN / Viridian Therapeutics, Inc.
QNCX / Quince Therapeutics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
NKTR / Nektar Therapeutics
ETNB / 89bio, Inc.
QURE / uniQure N.V.
RAPT / RAPT Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
SRRK / Scholar Rock Holding Corporation
KROS / Keros Therapeutics, Inc.
INSM / Insmed Incorporated
BBIO / BridgeBio Pharma, Inc.
SMMT / Summit Therapeutics Inc.
SVRA / Savara Inc.
URGN / UroGen Pharma Ltd.
CABA / Cabaletta Bio, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
IPSC / Century Therapeutics, Inc.
DRUG / Bright Minds Biosciences Inc.
ORIC / ORIC Pharmaceuticals, Inc.
VIR / Vir Biotechnology, Inc.
TARA / Protara Therapeutics, Inc.
BMEA / Biomea Fusion, Inc.
IQV / IQVIA Holdings Inc.
ZBIO / Zenas BioPharma, Inc.
UTHR / United Therapeutics Corporation
AXSM / Axsome Therapeutics, Inc.
CAPR / Capricor Therapeutics, Inc.